SHORT SHORT SHORT into oblivion $25 puts
Based on idea below: Should fill gap at 40 and proceed. Exit at 60.
Last higher low coincides with 20 SMA - which I think can act as safer stop-loss
An ARKG favorite, this briefly touched the 9 EMA and is going back up on strong buying volume. Yesterday was a gift from the gods of an entry point and a long hold for those who are in it to win it in a game-changing technology in a huge growth sector.
Called this out at $20.40 when wedge broke up, $PACB is a strong long term holding. Has run up massively this year but probably has more room to go, especially in the long term. A note on the two trendines. I had alerts on both these trendines. Why? It's a messy but clear downward wedge on a high beta, small cap. The 'way' that PACB (and the entire genomics...
Recently there are many small stocks that broke out of a long term base spanning 2 years or more. How do we identify penny stocks with good odds of being a multi-bagger? PACB is one such example with the right criteria that increased it's odds of having a trend that is sustainable to great extends. Criteria: 1. long term base/bottoming formation (preferably 2...
large volume large price increase and initial breakout price target 20-25% higher from current price. I own this stock after holding support at the 10day moving average. the fundamentals of genomic testing and widespread adoption is a significant trend driving change in the healthcare industry.
A well-needed healthy pullback occurred and touched the 50SMA - should see money pouring back in for the January effect around the corner. An $ARKG favorite with a heavy weighting in their portfolio. Perfect opportunity for sideliners to have taken a position today. Good luck!
Pacific Biosciences of California is a biotech company that develops and manufactures systems for gene sequencing and is currently the largest position in the ARK Genomic Revolution ETF which is the best performing ETF for ARK. The next big change to healthcare will be the ability to eliminate genetic diseases and prevent certain cancers due to the ability to...
Clear uptrend despite regular retracements up to 50%. Can it go another level up? Will wait and see.
Pacific Biosciences provides an integrated platform for genetic analysis and its sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology. Has had a nice steady run and seems to be able to stay within a tighter 12% trail. RSI is pretty high so if you are looking for an...